首页 > 最新文献

Journal of Clinical Medicine Research最新文献

英文 中文
Predictors of Catheter-Related Bladder Discomfort After Surgery: A Literature Review. 术后导尿管相关性膀胱不适的预测因素:文献综述。
Pub Date : 2023-04-01 DOI: 10.14740/jocmr4873
Yuta Mitobe, Tomomi Yoshioka, Yasuko Baba, Yuri Yamaguchi, Kenji Nakagawa, Takeshi Itou, Kiyoyasu Kurahashi

Background: Indwelling bladder catheters are routinely used in clinical practice. Patients may experience postoperative indwelling catheter-related bladder discomfort (CRBD). This study aimed to perform a literature review to identify predictors of postoperative CRBD.

Methods: We searched PubMed for relevant articles published between 2000 and 2020 using the search items "CRBD", "catheter-related bladder discomfort", and "prediction". Additionally, we searched for articles that matched the research objectives from the references of the extracted articles. We included only prospective observational studies involving human participants and excluded interventional studies, observational studies that did not report sample sizes, or observational studies that did not research on predictors of CRBD. We narrowed our search to the keyword "prediction" and found five references. We selected five studies that met the objectives of the study as the target literature.

Results: Using the keywords "CRBD" and "catheter-related bladder discomfort", we identified 69 published articles. The results were narrowed down by the keyword "prediction", and five studies that recruited 1,147 patients remained. The predictors of CRBD can be divided into four factors: 1) patient factors; 2) surgical factors; 3) anesthesia factors; and 4) device and insertion technique factors.

Conclusion: Our study suggests that patients with predictors of CRBD should be closely monitored to reduce postoperative patient suffering, and their quality of life should be improved after anesthesia.

背景:留置膀胱导尿管是临床常规应用。患者可能会经历术后留置导尿管相关的膀胱不适(CRBD)。本研究旨在进行文献综述,以确定术后CRBD的预测因素。方法:我们在PubMed检索2000 - 2020年间发表的相关文章,检索词为“CRBD”、“导管相关性膀胱不适”和“预测”。此外,我们从提取的文章的参考文献中搜索与研究目的相匹配的文章。我们只纳入了涉及人类受试者的前瞻性观察性研究,排除了干预性研究、未报告样本量的观察性研究或未研究CRBD预测因子的观察性研究。我们将搜索范围缩小到关键词“预测”,找到了五个参考文献。我们选择了5项符合研究目的的研究作为目标文献。结果:通过关键词“CRBD”和“导管相关性膀胱不适”,我们检索到69篇已发表的文章。结果通过关键词“预测”缩小了范围,五项研究招募了1147名患者。CRBD的预测因素可分为4个因素:1)患者因素;2)手术因素;3)麻醉因素;4)装置和插入技术因素。结论:我们的研究提示应密切监测伴有CRBD预测因子的患者,以减少患者术后的痛苦,并改善麻醉后患者的生活质量。
{"title":"Predictors of Catheter-Related Bladder Discomfort After Surgery: A Literature Review.","authors":"Yuta Mitobe,&nbsp;Tomomi Yoshioka,&nbsp;Yasuko Baba,&nbsp;Yuri Yamaguchi,&nbsp;Kenji Nakagawa,&nbsp;Takeshi Itou,&nbsp;Kiyoyasu Kurahashi","doi":"10.14740/jocmr4873","DOIUrl":"https://doi.org/10.14740/jocmr4873","url":null,"abstract":"<p><strong>Background: </strong>Indwelling bladder catheters are routinely used in clinical practice. Patients may experience postoperative indwelling catheter-related bladder discomfort (CRBD). This study aimed to perform a literature review to identify predictors of postoperative CRBD.</p><p><strong>Methods: </strong>We searched PubMed for relevant articles published between 2000 and 2020 using the search items \"CRBD\", \"catheter-related bladder discomfort\", and \"prediction\". Additionally, we searched for articles that matched the research objectives from the references of the extracted articles. We included only prospective observational studies involving human participants and excluded interventional studies, observational studies that did not report sample sizes, or observational studies that did not research on predictors of CRBD. We narrowed our search to the keyword \"prediction\" and found five references. We selected five studies that met the objectives of the study as the target literature.</p><p><strong>Results: </strong>Using the keywords \"CRBD\" and \"catheter-related bladder discomfort\", we identified 69 published articles. The results were narrowed down by the keyword \"prediction\", and five studies that recruited 1,147 patients remained. The predictors of CRBD can be divided into four factors: 1) patient factors; 2) surgical factors; 3) anesthesia factors; and 4) device and insertion technique factors.</p><p><strong>Conclusion: </strong>Our study suggests that patients with predictors of CRBD should be closely monitored to reduce postoperative patient suffering, and their quality of life should be improved after anesthesia.</p>","PeriodicalId":15431,"journal":{"name":"Journal of Clinical Medicine Research","volume":"15 4","pages":"208-215"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/d7/e1/jocmr-15-208.PMC10181350.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9477232","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Relationship Between Body Mass Index and Dysmenorrhea in the General Female Population. 普通女性体质指数与痛经的关系
Pub Date : 2023-04-01 DOI: 10.14740/jocmr4893
Keiko Takata, Kazuhiko Kotani, Hitoshi Umino

Background: There may be an etiological association between obesity and dysmenorrheal traits. This study aimed to observe the relationship between body mass index (BMI) and dysmenorrhea in a general female population.

Methods: Premenopausal adult females (n = 2,805) undergoing health checkups were assessed for data such as the BMI and self-reported severity of dysmenorrhea. The BMI levels were compared according to the severity of dysmenorrhea with adjustment for age, smoking habit, exercise habit, serum lipids, and plasma glucose.

Results: The mean BMI level in females with severe dysmenorrhea (n = 278; 23.3 ± 4.5 (standard deviation) kg/m2) was high relative to those with mild (n = 1,451; 22.3 ± 3.9 kg/m2) and moderate (n = 1,076; 22.6 ± 4.4 kg/m2) dysmenorrhea. Even after adjustment for covariables, the difference in BMI remained significant.

Conclusions: The high-normal BMI level may be seen in severe dysmenorrhea in the general female population. Further research is needed to confirm the findings.

背景:肥胖与痛经特征之间可能存在病因学关联。本研究旨在观察普通女性人群的身体质量指数(BMI)与痛经的关系。方法:对绝经前成年女性(n = 2,805)进行健康检查,评估其BMI和痛经严重程度等数据。根据痛经的严重程度比较BMI水平,并调整年龄、吸烟习惯、运动习惯、血脂和血糖。结果:重度痛经女性患者的平均BMI水平(n = 278;23.3±4.5(标准差)kg/m2)高于轻度患者(n = 1451;22.3±3.9 kg/m2)和中度(n = 1,076;(22.6±4.4 kg/m2)痛经。即使在调整协变量后,BMI的差异仍然显著。结论:在普通女性重度痛经患者中,存在BMI偏高的现象。需要进一步的研究来证实这些发现。
{"title":"The Relationship Between Body Mass Index and Dysmenorrhea in the General Female Population.","authors":"Keiko Takata,&nbsp;Kazuhiko Kotani,&nbsp;Hitoshi Umino","doi":"10.14740/jocmr4893","DOIUrl":"https://doi.org/10.14740/jocmr4893","url":null,"abstract":"<p><strong>Background: </strong>There may be an etiological association between obesity and dysmenorrheal traits. This study aimed to observe the relationship between body mass index (BMI) and dysmenorrhea in a general female population.</p><p><strong>Methods: </strong>Premenopausal adult females (n = 2,805) undergoing health checkups were assessed for data such as the BMI and self-reported severity of dysmenorrhea. The BMI levels were compared according to the severity of dysmenorrhea with adjustment for age, smoking habit, exercise habit, serum lipids, and plasma glucose.</p><p><strong>Results: </strong>The mean BMI level in females with severe dysmenorrhea (n = 278; 23.3 ± 4.5 (standard deviation) kg/m<sup>2</sup>) was high relative to those with mild (n = 1,451; 22.3 ± 3.9 kg/m<sup>2</sup>) and moderate (n = 1,076; 22.6 ± 4.4 kg/m<sup>2</sup>) dysmenorrhea. Even after adjustment for covariables, the difference in BMI remained significant.</p><p><strong>Conclusions: </strong>The high-normal BMI level may be seen in severe dysmenorrhea in the general female population. Further research is needed to confirm the findings.</p>","PeriodicalId":15431,"journal":{"name":"Journal of Clinical Medicine Research","volume":"15 4","pages":"239-242"},"PeriodicalIF":0.0,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f9/ba/jocmr-15-239.PMC10181351.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9829189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive Factors for the Necessity of Hospitalization of Patients With Acute Alcohol Intoxication. 急性酒精中毒患者住院必要性的预测因素。
Pub Date : 2023-03-01 DOI: 10.14740/jocmr4881
Hiroaki Takeoka, Ken Horibata, Shinta Masui, Hiroki Suzuyama, Kazuhiko Ajisaka, Shigeki Nabeshima

Background: The aim of the study was to identify factors related to the need for hospitalization due to acute alcohol intoxication.

Methods: The data of 42 patients with acute alcohol intoxication who visited our hospital from April 1, 2014 to September 30, 2015 were available for analysis. Factors related to outcome included hospitalization or release to home, Glasgow coma scale (GCS), temperature, pulse rate, blood pressure, oxygen saturation of the peripheral artery (SpO2), and respiratory rate. A retrospective survey was done that included estimated blood alcohol concentration, osmotic pressure, and serum lactate level. The following formula was used to estimate blood alcohol concentration: (measured osmotic pressure - estimated osmotic pressure × 4.6 mg/dL). Univariate analysis of each variable was done for the two outcome groups, hospital admission or release to home, then statistically significant items were subjected to multivariate analysis.

Results: Of the 42 patients (average age 22.8 ± 8.6 years, 33 men, six women), 29 were admitted and 13 were released to home. There was a weak correlation between estimated blood alcohol concentration and GCS. There was no significant difference in alcohol concentration or GCS between the hospitalized and released to home groups. In multivariate analysis using the outcome as the objective variable, a serum lactate level of 26 mg/dL or higher was associated with the need for hospitalization (odds ratio: 6.7).

Conclusion: A serum lactate level of 26 mg/dL would be useful for deciding if hospitalization is necessary for patients with acute alcohol intoxication.

背景:本研究的目的是确定因急性酒精中毒而需要住院的相关因素。方法:对2014年4月1日至2015年9月30日我院收治的42例急性酒精中毒患者资料进行分析。与结果相关的因素包括住院或出院回家、格拉斯哥昏迷评分(GCS)、体温、脉搏、血压、外周动脉氧饱和度(SpO2)和呼吸频率。回顾性调查包括估计血液酒精浓度、渗透压和血清乳酸水平。血液酒精浓度计算公式如下:(测量渗透压-估计渗透压× 4.6 mg/dL)。对住院或出院两个结果组的每个变量进行单因素分析,然后对具有统计学意义的项目进行多因素分析。结果:42例患者(平均年龄22.8±8.6岁,男33例,女6例),入院29例,出院13例。估计的血液酒精浓度与GCS之间存在弱相关性。在住院组和出院回家组之间,酒精浓度和GCS没有显著差异。在以结果为客观变量的多变量分析中,血清乳酸水平为26 mg/dL或更高与住院需求相关(优势比:6.7)。结论:血清乳酸水平为26 mg/dL可作为判断急性酒精中毒患者是否需要住院治疗的依据。
{"title":"Predictive Factors for the Necessity of Hospitalization of Patients With Acute Alcohol Intoxication.","authors":"Hiroaki Takeoka,&nbsp;Ken Horibata,&nbsp;Shinta Masui,&nbsp;Hiroki Suzuyama,&nbsp;Kazuhiko Ajisaka,&nbsp;Shigeki Nabeshima","doi":"10.14740/jocmr4881","DOIUrl":"https://doi.org/10.14740/jocmr4881","url":null,"abstract":"<p><strong>Background: </strong>The aim of the study was to identify factors related to the need for hospitalization due to acute alcohol intoxication.</p><p><strong>Methods: </strong>The data of 42 patients with acute alcohol intoxication who visited our hospital from April 1, 2014 to September 30, 2015 were available for analysis. Factors related to outcome included hospitalization or release to home, Glasgow coma scale (GCS), temperature, pulse rate, blood pressure, oxygen saturation of the peripheral artery (SpO<sub>2</sub>), and respiratory rate. A retrospective survey was done that included estimated blood alcohol concentration, osmotic pressure, and serum lactate level. The following formula was used to estimate blood alcohol concentration: (measured osmotic pressure - estimated osmotic pressure × 4.6 mg/dL). Univariate analysis of each variable was done for the two outcome groups, hospital admission or release to home, then statistically significant items were subjected to multivariate analysis.</p><p><strong>Results: </strong>Of the 42 patients (average age 22.8 ± 8.6 years, 33 men, six women), 29 were admitted and 13 were released to home. There was a weak correlation between estimated blood alcohol concentration and GCS. There was no significant difference in alcohol concentration or GCS between the hospitalized and released to home groups. In multivariate analysis using the outcome as the objective variable, a serum lactate level of 26 mg/dL or higher was associated with the need for hospitalization (odds ratio: 6.7).</p><p><strong>Conclusion: </strong>A serum lactate level of 26 mg/dL would be useful for deciding if hospitalization is necessary for patients with acute alcohol intoxication.</p>","PeriodicalId":15431,"journal":{"name":"Journal of Clinical Medicine Research","volume":"15 3","pages":"161-165"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0b/b4/jocmr-15-161.PMC10079366.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9642658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Risk Factors Associated With Atrial Fibrillation in Elderly Patients. 老年患者心房颤动的相关危险因素。
Pub Date : 2023-03-01 DOI: 10.14740/jocmr4884
Jeeyong Shin, Megha Andrews, Lindsey DeJean, Nicole Debski, Alyssa Exarchakis, Julia Fleming, Roshni Gandhi, Christina Hum, Abyson Kalladanthyil, Rohini Maddigunta, Logan Napoli, Cynthia Nguyen, Reshma Paul, Nicole Schmalbach, Joseph Sichel, Samuel Snyder, Matthew Stern, Subhadra Thampi, Jesse Viggiano, Gabriella Yao, Krystal Hunter, Satyajeet Roy

Background: Atrial fibrillation (AF) is the most common arrhythmia with a growing prevalence worldwide, especially in the elderly population. Patients with AF are at higher risk of serious life-threatening events and complications that may lead to long-term sequelae and reduce quality of life. The aim of our study was to examine the association of additional risk factors and comorbid medical conditions with AF in patients 65 years, or older.

Methods: We performed a retrospective electronic medical record review of patients aged 65 years and older, who visited our internal medicine office between July 1, 2020 and June 30, 2021.

Results: Among 2,433 patients, 418 patients (17.2%) had AF. Our analysis showed that for each unit increased in age, there was a 4.5% increase in the odds of AF (95% confidence interval (CI) 2.2-6.9%; P < 0.001). Compared to patients of Caucasian descent, African-American patients had significantly decreased odds of AF (odds ratio (OR) 0.274, 95% CI 0.141 - 0.531; P < 0.001). Patients with hypertension had 2.241 greater odds of AF (95% CI 1.421 - 3.534; P = 0.001). Additional comorbidities with significantly greater odds of AF included other cardiac arrhythmias (OR 2.523, 95% CI 1.720 - 3.720; P < 0.001), congestive heart failure (OR 3.111, 95% CI 1.674 - 5.784; P < 0.001), osteoarthritis (OR 3.014, 95% CI 2.138 - 4.247; P < 0.001), liver disease (OR 2.129, 95% CI 1.164 - 3.893; P = 0.014), and colorectal disease (OR 1.500 95% CI 1.003 - 2.243; P = 0.048). Comorbidities with significantly decreased odds of AF included other rheumatological disorder (OR 0.144, 95% CI 0.086 - 0.243; P < 0.001), non-steroidal anti-inflammatory drugs (NSAIDs) use (OR 0.206, 95% CI 0.125 - 0.338; P < 0.001), and corticosteroid use (OR 0.553, 95% CI 0.374 - 0.819; P = 0.003).

Conclusions: Increasing age, hypertension, presence of other cardiac arrhythmias, congestive heart failure, osteoarthritis, liver disease, and colorectal disease are associated with increased odds of having AF.

背景:房颤(AF)是最常见的心律失常,在世界范围内的发病率越来越高,尤其是在老年人群中。房颤患者发生严重危及生命事件和并发症的风险较高,可能导致长期后遗症并降低生活质量。本研究的目的是检查65岁及以上患者房颤的其他危险因素和合并症的相关性。方法:我们对2020年7月1日至2021年6月30日期间到我们内科办公室就诊的65岁及以上患者进行了回顾性电子病历回顾。结果:在2433例患者中,418例患者(17.2%)患有房颤。我们的分析显示,年龄每增加一个单位,房颤的几率增加4.5%(95%置信区间(CI) 2.2-6.9%;P < 0.001)。与白种人相比,非洲裔美国人患房颤的几率显著降低(优势比(OR) 0.274, 95% CI 0.141 - 0.531;P < 0.001)。高血压患者发生房颤的几率高出2.241 (95% CI 1.421 - 3.534;P = 0.001)。房颤发生率显著增加的其他合并症包括其他心律失常(OR 2.523, 95% CI 1.720 - 3.720;P < 0.001),充血性心力衰竭(OR 3.111, 95% CI 1.674 - 5.784;P < 0.001),骨关节炎(OR 3.014, 95% CI 2.138 - 4.247;P < 0.001),肝脏疾病(OR 2.129, 95% CI 1.164 - 3.893;P = 0.014)和结直肠疾病(OR 1.500 95% CI 1.003 - 2.243;P = 0.048)。房颤发生率显著降低的合并症包括其他风湿病(OR 0.144, 95% CI 0.086 - 0.243;P < 0.001),非甾体抗炎药(NSAIDs)的使用(OR 0.206, 95% CI 0.125 - 0.338;P < 0.001)和皮质类固醇使用(OR 0.553, 95% CI 0.374 - 0.819;P = 0.003)。结论:年龄增长、高血压、其他心律失常、充血性心力衰竭、骨关节炎、肝脏疾病和结直肠疾病与房颤发生率增加相关。
{"title":"Risk Factors Associated With Atrial Fibrillation in Elderly Patients.","authors":"Jeeyong Shin,&nbsp;Megha Andrews,&nbsp;Lindsey DeJean,&nbsp;Nicole Debski,&nbsp;Alyssa Exarchakis,&nbsp;Julia Fleming,&nbsp;Roshni Gandhi,&nbsp;Christina Hum,&nbsp;Abyson Kalladanthyil,&nbsp;Rohini Maddigunta,&nbsp;Logan Napoli,&nbsp;Cynthia Nguyen,&nbsp;Reshma Paul,&nbsp;Nicole Schmalbach,&nbsp;Joseph Sichel,&nbsp;Samuel Snyder,&nbsp;Matthew Stern,&nbsp;Subhadra Thampi,&nbsp;Jesse Viggiano,&nbsp;Gabriella Yao,&nbsp;Krystal Hunter,&nbsp;Satyajeet Roy","doi":"10.14740/jocmr4884","DOIUrl":"https://doi.org/10.14740/jocmr4884","url":null,"abstract":"<p><strong>Background: </strong>Atrial fibrillation (AF) is the most common arrhythmia with a growing prevalence worldwide, especially in the elderly population. Patients with AF are at higher risk of serious life-threatening events and complications that may lead to long-term sequelae and reduce quality of life. The aim of our study was to examine the association of additional risk factors and comorbid medical conditions with AF in patients 65 years, or older.</p><p><strong>Methods: </strong>We performed a retrospective electronic medical record review of patients aged 65 years and older, who visited our internal medicine office between July 1, 2020 and June 30, 2021.</p><p><strong>Results: </strong>Among 2,433 patients, 418 patients (17.2%) had AF. Our analysis showed that for each unit increased in age, there was a 4.5% increase in the odds of AF (95% confidence interval (CI) 2.2-6.9%; P < 0.001). Compared to patients of Caucasian descent, African-American patients had significantly decreased odds of AF (odds ratio (OR) 0.274, 95% CI 0.141 - 0.531; P < 0.001). Patients with hypertension had 2.241 greater odds of AF (95% CI 1.421 - 3.534; P = 0.001). Additional comorbidities with significantly greater odds of AF included other cardiac arrhythmias (OR 2.523, 95% CI 1.720 - 3.720; P < 0.001), congestive heart failure (OR 3.111, 95% CI 1.674 - 5.784; P < 0.001), osteoarthritis (OR 3.014, 95% CI 2.138 - 4.247; P < 0.001), liver disease (OR 2.129, 95% CI 1.164 - 3.893; P = 0.014), and colorectal disease (OR 1.500 95% CI 1.003 - 2.243; P = 0.048). Comorbidities with significantly decreased odds of AF included other rheumatological disorder (OR 0.144, 95% CI 0.086 - 0.243; P < 0.001), non-steroidal anti-inflammatory drugs (NSAIDs) use (OR 0.206, 95% CI 0.125 - 0.338; P < 0.001), and corticosteroid use (OR 0.553, 95% CI 0.374 - 0.819; P = 0.003).</p><p><strong>Conclusions: </strong>Increasing age, hypertension, presence of other cardiac arrhythmias, congestive heart failure, osteoarthritis, liver disease, and colorectal disease are associated with increased odds of having AF.</p>","PeriodicalId":15431,"journal":{"name":"Journal of Clinical Medicine Research","volume":"15 3","pages":"148-160"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/6d/0a/jocmr-15-148.PMC10079365.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9642660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor. 阿达木单抗联合强化粒细胞和单核细胞吸附采珠术治疗溃疡性结肠炎和常规药物、生物制剂和Janus激酶抑制剂治疗失败
Pub Date : 2023-03-01 DOI: 10.14740/jocmr4887
Satoshi Tanida, Keiji Ozeki, Takahito Katano, Mamoru Tanaka, Takaya Shimura, Eiji Kubota, Hiromi Kataoka, Takuya Takahama, Shun Sasoh, Yoshimasa Kubota, Tesshin Ban, Tomoaki Ando, Makoto Nakamura, Takashi Joh

Every-week (ew) adalimumab (ADA) maintenance following induction therapy with a standard induction regimen has recently been approved for use in Japan. The efficacy and safety of combination therapy with ew-ADA maintenance following standard induction regimen plus intensive granulocyte and monocyte adsorptive apheresis (GMA) (two sessions/week) for the treatment of refractory ulcerative colitis (UC) displaying failure of conventional, biologics and Janus kinase inhibitor have not been evaluated previously. The present retrospective study evaluated the 10-week efficacy of this combination therapy among refractory UC patients. Six patients were given initial ADA combination therapy (ADA at 160 mg in week 0, ADA 80 mg in week 2, and 40 mg in week 4, followed by ew-ADA at 40 mg/week) plus intensive GMA. One patient (16.6%) achieved clinical remission and two patients (33.3%) achieved endoscopic improvement by week 10. After excluding two patients who discontinued treatment, mean full Mayo score (P = 0.14), endoscopic subscore (P = 0.18) and C-reactive protein level (P = 0.27) at 10 weeks were numerically decreased compared with baseline in the remaining four cases, although the differences were not significant. Use of ew-ADA maintenance following standard induction regimen plus intensive GMA appears unlikely to achieve satisfactory induction of clinical remission in UC patients for whom conventional agents, biologics and Janus kinase inhibitors have failed.

诱导治疗后每周(新)阿达木单抗(ADA)维持标准诱导方案最近已被批准在日本使用。对于难治性溃疡性结肠炎(UC),在常规、生物制剂和Janus激酶抑制剂治疗失败的情况下,在标准诱导方案下联合使用新ada维持加上强化粒细胞和单核细胞吸附采珠术(GMA)(2次/周)的疗效和安全性尚未得到评估。目前的回顾性研究评估了这种联合治疗在难治性UC患者中的10周疗效。6例患者接受初始ADA联合治疗(第0周ADA 160 mg,第2周ADA 80 mg,第4周40 mg,随后是新ADA 40 mg/周)加强化GMA。到第10周,1例患者(16.6%)达到临床缓解,2例患者(33.3%)达到内镜改善。在排除2例停止治疗的患者后,其余4例患者在10周时的平均完全Mayo评分(P = 0.14)、内镜亚评分(P = 0.18)和c反应蛋白水平(P = 0.27)与基线相比在数值上有所下降,但差异不显著。在常规药物、生物制剂和Janus激酶抑制剂治疗失败的UC患者中,使用标准诱导方案后的ew-ADA维持加上强化GMA似乎不太可能达到令人满意的临床缓解诱导。
{"title":"Induction Therapy With a Combination of Weekly Adalimumab Plus Intensive Granulocyte and Monocyte Adsorptive Apheresis in Patients With Ulcerative Colitis and Failure of Conventional Agents, Biologics and Janus Kinase Inhibitor.","authors":"Satoshi Tanida,&nbsp;Keiji Ozeki,&nbsp;Takahito Katano,&nbsp;Mamoru Tanaka,&nbsp;Takaya Shimura,&nbsp;Eiji Kubota,&nbsp;Hiromi Kataoka,&nbsp;Takuya Takahama,&nbsp;Shun Sasoh,&nbsp;Yoshimasa Kubota,&nbsp;Tesshin Ban,&nbsp;Tomoaki Ando,&nbsp;Makoto Nakamura,&nbsp;Takashi Joh","doi":"10.14740/jocmr4887","DOIUrl":"https://doi.org/10.14740/jocmr4887","url":null,"abstract":"<p><p>Every-week (ew) adalimumab (ADA) maintenance following induction therapy with a standard induction regimen has recently been approved for use in Japan. The efficacy and safety of combination therapy with ew-ADA maintenance following standard induction regimen plus intensive granulocyte and monocyte adsorptive apheresis (GMA) (two sessions/week) for the treatment of refractory ulcerative colitis (UC) displaying failure of conventional, biologics and Janus kinase inhibitor have not been evaluated previously. The present retrospective study evaluated the 10-week efficacy of this combination therapy among refractory UC patients. Six patients were given initial ADA combination therapy (ADA at 160 mg in week 0, ADA 80 mg in week 2, and 40 mg in week 4, followed by ew-ADA at 40 mg/week) plus intensive GMA. One patient (16.6%) achieved clinical remission and two patients (33.3%) achieved endoscopic improvement by week 10. After excluding two patients who discontinued treatment, mean full Mayo score (P = 0.14), endoscopic subscore (P = 0.18) and C-reactive protein level (P = 0.27) at 10 weeks were numerically decreased compared with baseline in the remaining four cases, although the differences were not significant. Use of ew-ADA maintenance following standard induction regimen plus intensive GMA appears unlikely to achieve satisfactory induction of clinical remission in UC patients for whom conventional agents, biologics and Janus kinase inhibitors have failed.</p>","PeriodicalId":15431,"journal":{"name":"Journal of Clinical Medicine Research","volume":"15 3","pages":"181-186"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f2/70/jocmr-15-181.PMC10079367.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9642662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Prevalence and Associated Predictors for Diabetes Mellitus in Adult Patients With Thyroid Nodules. 成年甲状腺结节患者糖尿病的患病率及相关预测因素
Pub Date : 2023-03-01 DOI: 10.14740/jocmr4886
Hussain Alyousif, Mona A Sid Ahmed, Ahmed M Khair, Faisal H Alharbi, Soha Hassan, Nusaiba M Elbadwi, Imad R Musa

Background: Diabetes mellitus (DM) and thyroid nodules (TNs) with the risk of malignancy are increasing globally. Hence, we conducted this study to evaluate the prevalence and the associated predictors for DM among adult patients with TNs in Royal Commission Hospital, Kingdom of Saudi Arabia (KSA).

Methods: A retrospective study was conducted between January 1, 2015 and December 31, 2021. Patients with documented TNs based on the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) were recruited. Then the prevalence and associated risk factors for DM were assessed.

Result: Three hundred ninety-one patients who had TNs were recruited. The median (interquartile range (IQR)) age was 46.00 (20.0) years, and 332 (84.9%) of the patients were females. There was a high prevalence of DM (24.0%) among adult patients with TNs. In the univariate analysis, there were significant associations between diagnosed DM among adult patients with TNs and age, gender, 25-hydroxyvitamin D (25(OH)D) level, hypertension, bronchial asthma, free triiodothyronine (FT3), white blood cell count, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglycerides. In the multivariate analysis, there were significant associations between diagnosed DM among adult patients with TNs and age (odds ratio (OR) 1.037 (95% confidence interval (CI) 1.012 - 1.062)), hypertension (OR 0.374 (95% CI 0.203 - 0.689)), FT3 level (OR 0.635 (95% CI 0.412 - 0.980)), LDL (OR 0.643 (95% CI 0.456 - 0.907)) and HDL (OR 0.654 (95% CI 0.465 - 0.919)).

Conclusion: There was a high prevalence of DM among patients with TNs. Age, hypertension, FT3, LDL and HDL were significantly associated with DM and TNs.

背景:糖尿病(DM)和甲状腺结节(TNs)伴恶性肿瘤的风险在全球范围内呈上升趋势。因此,我们进行了这项研究,以评估沙特阿拉伯王国皇家委员会医院(KSA)成年TNs患者中糖尿病的患病率和相关预测因素。方法:2015年1月1日至2021年12月31日进行回顾性研究。我们招募了根据美国放射学会甲状腺影像报告和数据系统(ACR TI-RADS)记录的TNs患者。然后评估糖尿病的患病率和相关危险因素。结果:共纳入391例TNs患者。年龄中位数(四分位间距(IQR))为46.00(20.0)岁,女性332例(84.9%)。成年TNs患者中DM患病率较高(24.0%)。在单因素分析中,诊断为糖尿病的成年TNs患者与年龄、性别、25-羟基维生素D (25(OH)D)水平、高血压、支气管哮喘、游离三碘甲状腺原氨酸(FT3)、白细胞计数、低密度脂蛋白(LDL)、高密度脂蛋白(HDL)和甘油三酯之间存在显著相关性。在多因素分析中,诊断为糖尿病的成年TNs患者与年龄(比值比(OR) 1.037(95%可信区间(CI) 1.012 - 1.062))、高血压(OR 0.374 (95% CI 0.203 - 0.689))、FT3水平(OR 0.635 (95% CI 0.412 - 0.980))、LDL (OR 0.643 (95% CI 0.456 - 0.907)和HDL (OR 0.654 (95% CI 0.465 - 0.919))存在显著相关。结论:糖尿病在TNs患者中患病率较高。年龄、高血压、FT3、LDL、HDL与DM、tnn显著相关。
{"title":"The Prevalence and Associated Predictors for Diabetes Mellitus in Adult Patients With Thyroid Nodules.","authors":"Hussain Alyousif,&nbsp;Mona A Sid Ahmed,&nbsp;Ahmed M Khair,&nbsp;Faisal H Alharbi,&nbsp;Soha Hassan,&nbsp;Nusaiba M Elbadwi,&nbsp;Imad R Musa","doi":"10.14740/jocmr4886","DOIUrl":"https://doi.org/10.14740/jocmr4886","url":null,"abstract":"<p><strong>Background: </strong>Diabetes mellitus (DM) and thyroid nodules (TNs) with the risk of malignancy are increasing globally. Hence, we conducted this study to evaluate the prevalence and the associated predictors for DM among adult patients with TNs in Royal Commission Hospital, Kingdom of Saudi Arabia (KSA).</p><p><strong>Methods: </strong>A retrospective study was conducted between January 1, 2015 and December 31, 2021. Patients with documented TNs based on the American College of Radiology Thyroid Imaging Reporting and Data System (ACR TI-RADS) were recruited. Then the prevalence and associated risk factors for DM were assessed.</p><p><strong>Result: </strong>Three hundred ninety-one patients who had TNs were recruited. The median (interquartile range (IQR)) age was 46.00 (20.0) years, and 332 (84.9%) of the patients were females. There was a high prevalence of DM (24.0%) among adult patients with TNs. In the univariate analysis, there were significant associations between diagnosed DM among adult patients with TNs and age, gender, 25-hydroxyvitamin D (25(OH)D) level, hypertension, bronchial asthma, free triiodothyronine (FT3), white blood cell count, low-density lipoprotein (LDL), high-density lipoprotein (HDL) and triglycerides. In the multivariate analysis, there were significant associations between diagnosed DM among adult patients with TNs and age (odds ratio (OR) 1.037 (95% confidence interval (CI) 1.012 - 1.062)), hypertension (OR 0.374 (95% CI 0.203 - 0.689)), FT3 level (OR 0.635 (95% CI 0.412 - 0.980)), LDL (OR 0.643 (95% CI 0.456 - 0.907)) and HDL (OR 0.654 (95% CI 0.465 - 0.919)).</p><p><strong>Conclusion: </strong>There was a high prevalence of DM among patients with TNs. Age, hypertension, FT3, LDL and HDL were significantly associated with DM and TNs.</p>","PeriodicalId":15431,"journal":{"name":"Journal of Clinical Medicine Research","volume":"15 3","pages":"166-173"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/88/e5/jocmr-15-166.PMC10079371.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9273315","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Trial of Adding Lung Protective Strategies to Existing Enhanced Recovery After Surgery Protocols and Its Effect on Improving Postoperative Lung Function. 在现有的增强术后恢复方案中加入肺保护策略的试验及其对改善术后肺功能的影响。
Pub Date : 2023-03-01 DOI: 10.14740/jocmr4871
David A Gutman, Victoria Bailey, Phillip Wilson, Andrew Fisher, Christopher A Skorke, Carey Brewbaker, Travis Pecha, Dulaney A Wilson, John Butler

Background: With this rising popularization of enhanced recovery after surgery (ERAS) protocols, it is important to ask if the current and developing pathways are fully comprehensive for the patient's perioperative experience. Many current pathways discuss aspects of care including fluid management, pain management, and anti-emetic medication regiments, but few delineate recommendations for lung protective strategies. The hypothesis was that intraoperative lung protective strategies would results in improved postoperative lung function.

Methods: One hundred patients at the Medical University of South Carolina undergoing hepatobiliary and colorectal surgeries were randomized to receive intraoperative lung protective techniques or a standard intraoperative ventilation management. Three maximum vital capacity breaths were recorded preoperatively, and postoperatively 30 min, 1 h, and 2 h after anesthesia stop time. Average maximum capacity breaths from all four data collection interactions were analyzed between both study and control cohorts.

Results: There was no significant difference in the preoperative inspiratory capacity between the control and the ERAS group (2,043.3 ± 628.4 mL vs. 2,012.2 ± 895.2 mL; P = 0.84). Additional data analysis showed no statistically significant difference between ERAS and control groups: total average of the inspiratory capacity volumes (1,253.5 ± 593.7 mL vs. 1,390.4 ± 964.9 mL; P = 0.47), preoperative oxygen saturation (97.76±2.3% vs. 98.04±1.7%; P = 0.50), the postoperative oxygen saturation (98.51±1.4% vs. 96.83±14.2%; P = 0.40), and change in inspiratory capacity (95% confidence interval (CI) (-211.2 - 366.6); P = 0.60).

Conclusions: No statistically significant difference in postoperative inspiratory capacities were seen after the implementation of intraoperative lung protective strategies. The addition of other indicators of postoperative lung function like pneumonia incidence or length of inpatient stay while receiving oxygen treatment could provide a fuller picture in future studies, but a higher power will be needed.

背景:随着手术后增强恢复(ERAS)方案的日益普及,重要的是要询问当前和正在发展的途径是否对患者的围手术期体验完全全面。目前许多途径讨论了包括液体管理、疼痛管理和止吐药物治疗在内的护理方面,但很少有关于肺保护策略的建议。假设术中肺保护策略可以改善术后肺功能。方法:在南卡罗来纳医科大学接受肝胆和结直肠手术的100例患者随机接受术中肺保护技术或标准术中通气管理。术前、术后30 min、1 h、2 h分别记录3次最大生命容量呼吸。在研究和对照队列之间分析所有四个数据收集交互产生的平均最大呼吸量。结果:对照组与ERAS组术前吸气量差异无统计学意义(2043.3±628.4 mL vs. 2012.2±895.2 mL;P = 0.84)。其他数据分析显示ERAS组与对照组之间无统计学差异:总平均吸气量(1,253.5±593.7 mL vs. 1,390.4±964.9 mL);P = 0.47),术前血氧饱和度(97.76±2.3% vs. 98.04±1.7%;P = 0.50),术后血氧饱和度(98.51±1.4%∶96.83±14.2%;P = 0.40),吸气量变化(95%置信区间(CI) (-211.2 - 366.6);P = 0.60)。结论:术中肺保护策略实施后,术后吸气量无统计学差异。术后肺功能的其他指标,如肺炎发病率、住院时间等,在未来的研究中可以提供更全面的信息,但需要更大的力量。
{"title":"A Trial of Adding Lung Protective Strategies to Existing Enhanced Recovery After Surgery Protocols and Its Effect on Improving Postoperative Lung Function.","authors":"David A Gutman,&nbsp;Victoria Bailey,&nbsp;Phillip Wilson,&nbsp;Andrew Fisher,&nbsp;Christopher A Skorke,&nbsp;Carey Brewbaker,&nbsp;Travis Pecha,&nbsp;Dulaney A Wilson,&nbsp;John Butler","doi":"10.14740/jocmr4871","DOIUrl":"https://doi.org/10.14740/jocmr4871","url":null,"abstract":"<p><strong>Background: </strong>With this rising popularization of enhanced recovery after surgery (ERAS) protocols, it is important to ask if the current and developing pathways are fully comprehensive for the patient's perioperative experience. Many current pathways discuss aspects of care including fluid management, pain management, and anti-emetic medication regiments, but few delineate recommendations for lung protective strategies. The hypothesis was that intraoperative lung protective strategies would results in improved postoperative lung function.</p><p><strong>Methods: </strong>One hundred patients at the Medical University of South Carolina undergoing hepatobiliary and colorectal surgeries were randomized to receive intraoperative lung protective techniques or a standard intraoperative ventilation management. Three maximum vital capacity breaths were recorded preoperatively, and postoperatively 30 min, 1 h, and 2 h after anesthesia stop time. Average maximum capacity breaths from all four data collection interactions were analyzed between both study and control cohorts.</p><p><strong>Results: </strong>There was no significant difference in the preoperative inspiratory capacity between the control and the ERAS group (2,043.3 ± 628.4 mL vs. 2,012.2 ± 895.2 mL; P = 0.84). Additional data analysis showed no statistically significant difference between ERAS and control groups: total average of the inspiratory capacity volumes (1,253.5 ± 593.7 mL vs. 1,390.4 ± 964.9 mL; P = 0.47), preoperative oxygen saturation (97.76±2.3% vs. 98.04±1.7%; P = 0.50), the postoperative oxygen saturation (98.51±1.4% vs. 96.83±14.2%; P = 0.40), and change in inspiratory capacity (95% confidence interval (CI) (-211.2 - 366.6); P = 0.60).</p><p><strong>Conclusions: </strong>No statistically significant difference in postoperative inspiratory capacities were seen after the implementation of intraoperative lung protective strategies. The addition of other indicators of postoperative lung function like pneumonia incidence or length of inpatient stay while receiving oxygen treatment could provide a fuller picture in future studies, but a higher power will be needed.</p>","PeriodicalId":15431,"journal":{"name":"Journal of Clinical Medicine Research","volume":"15 3","pages":"127-132"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/38/3f/jocmr-15-127.PMC10079370.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9273316","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Using Machine Learning Algorithms to Predict Patient Portal Use Among Emergency Department Patients With Diabetes Mellitus. 使用机器学习算法预测急诊科糖尿病患者的患者门户使用情况。
Pub Date : 2023-03-01 DOI: 10.14740/jocmr4862
Yuan Zhou, Thomas K Swoboda, Zehao Ye, Michael Barbaro, Jake Blalock, Danny Zheng, Hao Wang

Background: Different machine learning (ML) technologies have been applied in healthcare systems with diverse applications. We aimed to determine the model feasibility and accuracy of predicting patient portal use among diabetic patients by using six different ML algorithms. In addition, we also compared model performance accuracy with the use of only essential variables.

Methods: This was a single-center retrospective observational study. From March 1, 2019 to February 28, 2020, we included all diabetic patients from the study emergency department (ED). The primary outcome was the status of patient portal use. A total of 18 variables consisting of patient sociodemographic characteristics, ED and clinic information, and patient medical conditions were included to predict patient portal use. Six ML algorithms (logistic regression, random forest (RF), deep forest, decision tree, multilayer perception, and support vector machine) were used for such predictions. During the initial step, ML predictions were performed with all variables. Then, the essential variables were chosen via feature selection. Patient portal use predictions were repeated with only essential variables. The performance accuracies (overall accuracy, sensitivity, specificity, and area under receiver operating characteristic curve (AUC)) of patient portal predictions were compared.

Results: A total of 77,977 unique patients were placed in our final analysis. Among them, 23.4% (18,223) patients were diabetic mellitus (DM). Patient portal use was found in 26.9% of DM patients. Overall, the accuracy of predicting patient portal use was above 80% among five out of six ML algorithms. The RF outperformed the others when all variables were used for patient portal predictions (accuracy 0.9876, sensitivity 0.9454, specificity 0.9969, and AUC 0.9712). When only eight essential variables were chosen, RF still outperformed the others (accuracy 0.9876, sensitivity 0.9374, specificity 0.9932, and AUC 0.9769).

Conclusion: It is possible to predict patient portal use outcomes when different ML algorithms are used with fair performance accuracy. However, with similar prediction accuracies, the use of feature selection techniques can improve the interpretability of the model by addressing the most relevant features.

背景:不同的机器学习(ML)技术在医疗保健系统中有不同的应用。我们的目的是通过使用六种不同的ML算法来确定预测糖尿病患者门静脉使用的模型可行性和准确性。此外,我们还比较了仅使用基本变量的模型性能准确性。方法:本研究为单中心回顾性观察性研究。从2019年3月1日至2020年2月28日,我们纳入了研究急诊科(ED)的所有糖尿病患者。主要观察指标为患者门静脉使用情况。共纳入18个变量,包括患者社会人口学特征、ED和临床信息以及患者医疗状况,以预测患者门户网站的使用情况。六种机器学习算法(逻辑回归,随机森林(RF),深度森林,决策树,多层感知和支持向量机)用于此类预测。在初始步骤中,使用所有变量执行ML预测。然后,通过特征选择选择基本变量。仅使用基本变量重复患者门户使用预测。比较患者门脉预测的性能准确性(总体准确性、敏感性、特异性和接受者工作特征曲线下面积(AUC))。结果:共有77,977名独特的患者被纳入我们的最终分析。其中糖尿病(DM)患者占23.4%(18223例)。26.9%的糖尿病患者有门静脉使用。总体而言,六种ML算法中有五种预测患者门户使用的准确性超过80%。当所有变量用于患者门脉预测时,RF优于其他变量(准确性0.9876,灵敏度0.9454,特异性0.9969,AUC 0.9712)。当仅选择8个基本变量时,RF仍然优于其他变量(准确性0.9876,灵敏度0.9374,特异性0.9932,AUC 0.9769)。结论:当使用不同的机器学习算法时,以公平的性能准确性预测患者门户使用结果是可能的。然而,在类似的预测精度下,使用特征选择技术可以通过处理最相关的特征来提高模型的可解释性。
{"title":"Using Machine Learning Algorithms to Predict Patient Portal Use Among Emergency Department Patients With Diabetes Mellitus.","authors":"Yuan Zhou,&nbsp;Thomas K Swoboda,&nbsp;Zehao Ye,&nbsp;Michael Barbaro,&nbsp;Jake Blalock,&nbsp;Danny Zheng,&nbsp;Hao Wang","doi":"10.14740/jocmr4862","DOIUrl":"https://doi.org/10.14740/jocmr4862","url":null,"abstract":"<p><strong>Background: </strong>Different machine learning (ML) technologies have been applied in healthcare systems with diverse applications. We aimed to determine the model feasibility and accuracy of predicting patient portal use among diabetic patients by using six different ML algorithms. In addition, we also compared model performance accuracy with the use of only essential variables.</p><p><strong>Methods: </strong>This was a single-center retrospective observational study. From March 1, 2019 to February 28, 2020, we included all diabetic patients from the study emergency department (ED). The primary outcome was the status of patient portal use. A total of 18 variables consisting of patient sociodemographic characteristics, ED and clinic information, and patient medical conditions were included to predict patient portal use. Six ML algorithms (logistic regression, random forest (RF), deep forest, decision tree, multilayer perception, and support vector machine) were used for such predictions. During the initial step, ML predictions were performed with all variables. Then, the essential variables were chosen via feature selection. Patient portal use predictions were repeated with only essential variables. The performance accuracies (overall accuracy, sensitivity, specificity, and area under receiver operating characteristic curve (AUC)) of patient portal predictions were compared.</p><p><strong>Results: </strong>A total of 77,977 unique patients were placed in our final analysis. Among them, 23.4% (18,223) patients were diabetic mellitus (DM). Patient portal use was found in 26.9% of DM patients. Overall, the accuracy of predicting patient portal use was above 80% among five out of six ML algorithms. The RF outperformed the others when all variables were used for patient portal predictions (accuracy 0.9876, sensitivity 0.9454, specificity 0.9969, and AUC 0.9712). When only eight essential variables were chosen, RF still outperformed the others (accuracy 0.9876, sensitivity 0.9374, specificity 0.9932, and AUC 0.9769).</p><p><strong>Conclusion: </strong>It is possible to predict patient portal use outcomes when different ML algorithms are used with fair performance accuracy. However, with similar prediction accuracies, the use of feature selection techniques can improve the interpretability of the model by addressing the most relevant features.</p>","PeriodicalId":15431,"journal":{"name":"Journal of Clinical Medicine Research","volume":"15 3","pages":"133-138"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/bf/85/jocmr-15-133.PMC10079369.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9273317","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Public Stigma Related to People With Mental Health Conditions Among Japanese Company Employees. 日本公司员工中与心理健康状况相关的公众耻辱
Pub Date : 2023-03-01 DOI: 10.14740/jocmr4868
Wey Guan Lem, Kelssy Hitomi Dos Santos Kawata, Takashi Kobayashi, Hiroshi Oyama

Background: The public stigma related to mental illness is the general public's negative misconceptions about people with mental health conditions (PMHCs). The public stigma of mental illness is detrimental to PMHC as it leads to loss of opportunities and unemployment. The aim of the study was to clarify the status of public stigma related to PMHC, focusing on knowledge about mental illness and social distance concerning PMHC.

Methods: A survey was conducted among 970 Japanese office workers aged 20 to 60 years. Accurate knowledge of mental illness was assessed using the Mental Illness and Disorder Understanding Scale (MIDUS). The Attitudinal Social Distance (ASD) was used to determine social distance in relation to PMHC. The demographic characteristics of the participants evaluated were sex, age group measured in years, employment position, employment status, and attendance at mental illness stigma training.

Results: Regular employees (P = 0.03) and those having prior contact experience (P = 0.01) had more accurate knowledge. Participants between 50 to 59 years old (M = 15.87, standard deviation (SD) = 3.35) had greater social distance than those under 30 years old (M = 14.78, SD = 3.97, P < 0.05). The results of multiple linear regression analysis found that employment status (partial r = -0.07, P < 0.05) and prior contact experience (partial r = -0.15, P < 0.01) significantly affected the MIDUS score, whereas no variable had a significant effect on the ASD score.

Conclusions: Accurate knowledge of mental illness was significantly higher among regular employees and those with contact experience. Social distance was significantly lower among those under the age of 30 years.

背景:与精神疾病相关的公众耻辱感是公众对精神疾病患者的负面误解。公众对精神疾病的耻辱感不利于PMHC,因为它会导致失去机会和失业。本研究的目的是澄清与PMHC相关的公众耻辱感的现状,重点关注与PMHC相关的精神疾病知识和社会距离。方法:对970名20 ~ 60岁的日本上班族进行调查。使用精神疾病和障碍理解量表(MIDUS)评估对精神疾病的准确认识。采用态度社会距离(ASD)来确定与PMHC相关的社会距离。评估参与者的人口统计学特征为性别、以年为单位的年龄组、就业职位、就业状况和参加精神疾病污名培训的情况。结果:正职员工(P = 0.03)和有接触经验的员工(P = 0.01)的认知准确性更高。50 ~ 59岁被试(M = 15.87,标准差(SD) = 3.35)的社会距离高于30岁以下被试(M = 14.78, SD = 3.97, P < 0.05)。多元线性回归分析结果发现,就业状态(偏r = -0.07, P < 0.05)和先前接触经验(偏r = -0.15, P < 0.01)显著影响MIDUS得分,而变量对ASD得分无显著影响。结论:普通员工和有接触经验的员工对精神疾病的准确认知显著高于普通员工。30岁以下人群的社交距离明显较低。
{"title":"Public Stigma Related to People With Mental Health Conditions Among Japanese Company Employees.","authors":"Wey Guan Lem,&nbsp;Kelssy Hitomi Dos Santos Kawata,&nbsp;Takashi Kobayashi,&nbsp;Hiroshi Oyama","doi":"10.14740/jocmr4868","DOIUrl":"https://doi.org/10.14740/jocmr4868","url":null,"abstract":"<p><strong>Background: </strong>The public stigma related to mental illness is the general public's negative misconceptions about people with mental health conditions (PMHCs). The public stigma of mental illness is detrimental to PMHC as it leads to loss of opportunities and unemployment. The aim of the study was to clarify the status of public stigma related to PMHC, focusing on knowledge about mental illness and social distance concerning PMHC.</p><p><strong>Methods: </strong>A survey was conducted among 970 Japanese office workers aged 20 to 60 years. Accurate knowledge of mental illness was assessed using the Mental Illness and Disorder Understanding Scale (MIDUS). The Attitudinal Social Distance (ASD) was used to determine social distance in relation to PMHC. The demographic characteristics of the participants evaluated were sex, age group measured in years, employment position, employment status, and attendance at mental illness stigma training.</p><p><strong>Results: </strong>Regular employees (P = 0.03) and those having prior contact experience (P = 0.01) had more accurate knowledge. Participants between 50 to 59 years old (M = 15.87, standard deviation (SD) = 3.35) had greater social distance than those under 30 years old (M = 14.78, SD = 3.97, P < 0.05). The results of multiple linear regression analysis found that employment status (partial r = -0.07, P < 0.05) and prior contact experience (partial r = -0.15, P < 0.01) significantly affected the MIDUS score, whereas no variable had a significant effect on the ASD score.</p><p><strong>Conclusions: </strong>Accurate knowledge of mental illness was significantly higher among regular employees and those with contact experience. Social distance was significantly lower among those under the age of 30 years.</p>","PeriodicalId":15431,"journal":{"name":"Journal of Clinical Medicine Research","volume":"15 3","pages":"139-147"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/15/8b/jocmr-15-139.PMC10079372.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9642659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Remimazolam as a Primary Agent for Brief Invasive and Noninvasive Procedures: A Case Series. 雷马唑仑作为短期侵入性和非侵入性手术的主要药物:一个病例系列。
Pub Date : 2023-03-01 DOI: 10.14740/jocmr4870
Jessica Yeh, Christopher McKee, Kristin Chenault, Joseph D Tobias

Remimazolam is a novel benzodiazepine with sedative and amnestic properties similar to midazolam. Ester metabolism results in a half-life of 5 - 10 min and a limited context sensitive half-life. We present preliminary retrospective experience with its use as a primary agent for procedural sedation for brief invasive and noninvasive procedures. The study cohort included seven patients, ranging in age from 14 to 51 years. Remimazolam administration included bolus dosing in two patients and a combination of bolus dosing followed by an infusion in the other five patients. The initial bolus dose of remimazolam ranged from 2.5 to 5 mg. Starting doses for the infusion ranged from 10 to 30 µg/kg/min with titration of the continuous infusion during the procedure, ranging from 10 - 30 µg/kg/min. Median dose infusion requirements were 15 - 20 µg/kg/min. One procedure was completed with remimazolam as the sole anesthetic agent while the other six patients received adjunctive agents. Changes in blood pressure or oxygen saturation were noted which resolved with minimal interventions such as a decrease in remimazolam infusion rate or an increase in supplemental oxygen administration. Our anecdotal experience provides further support for the efficacy of remimazolam as an agent for procedural sedation.

雷马唑仑是一种新型苯二氮卓类药物,具有类似咪达唑仑的镇静和遗忘特性。酯代谢导致5 - 10分钟的半衰期和有限的环境敏感半衰期。我们提出初步的回顾性经验,其作为主要药物的程序镇静短暂的侵入性和非侵入性的程序。研究队列包括7名患者,年龄从14岁到51岁不等。雷马唑仑给药包括两名患者的单次给药和另外五名患者的单次给药后输液联合给药。雷马唑仑的初始剂量为2.5至5mg。起始剂量范围为10 - 30µg/kg/min,过程中持续滴注,范围为10 - 30µg/kg/min。中位注射剂量要求为15 - 20µg/kg/min。其中1例手术以雷马唑仑作为唯一麻醉剂完成,而其他6例患者接受辅助麻醉剂。注意到血压或血氧饱和度的变化,这些变化可以通过最小的干预措施解决,例如降低雷马唑仑输注速率或增加补充氧给药。我们的轶事经验进一步支持雷马唑仑作为程序镇静剂的有效性。
{"title":"Remimazolam as a Primary Agent for Brief Invasive and Noninvasive Procedures: A Case Series.","authors":"Jessica Yeh,&nbsp;Christopher McKee,&nbsp;Kristin Chenault,&nbsp;Joseph D Tobias","doi":"10.14740/jocmr4870","DOIUrl":"https://doi.org/10.14740/jocmr4870","url":null,"abstract":"<p><p>Remimazolam is a novel benzodiazepine with sedative and amnestic properties similar to midazolam. Ester metabolism results in a half-life of 5 - 10 min and a limited context sensitive half-life. We present preliminary retrospective experience with its use as a primary agent for procedural sedation for brief invasive and noninvasive procedures. The study cohort included seven patients, ranging in age from 14 to 51 years. Remimazolam administration included bolus dosing in two patients and a combination of bolus dosing followed by an infusion in the other five patients. The initial bolus dose of remimazolam ranged from 2.5 to 5 mg. Starting doses for the infusion ranged from 10 to 30 µg/kg/min with titration of the continuous infusion during the procedure, ranging from 10 - 30 µg/kg/min. Median dose infusion requirements were 15 - 20 µg/kg/min. One procedure was completed with remimazolam as the sole anesthetic agent while the other six patients received adjunctive agents. Changes in blood pressure or oxygen saturation were noted which resolved with minimal interventions such as a decrease in remimazolam infusion rate or an increase in supplemental oxygen administration. Our anecdotal experience provides further support for the efficacy of remimazolam as an agent for procedural sedation.</p>","PeriodicalId":15431,"journal":{"name":"Journal of Clinical Medicine Research","volume":"15 3","pages":"174-180"},"PeriodicalIF":0.0,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0d/f6/jocmr-15-174.PMC10079368.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9642661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Journal of Clinical Medicine Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1